da Silva-Coelho, Pedro <br/><br/>
Clonal evolution in myelodysplastic syndromes.  [electronic resource] 

 -  Nature communications  04 2017 
 - 15099 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/ncomms15099  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Bone Marrow Cells--drug effects<br/>Clonal Evolution--drug effects<br/>Disease Management<br/>Disease Progression<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Follow-Up Studies<br/>GTP Phosphohydrolases--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Lenalidomide<br/>Male<br/>Membrane Proteins--genetics<br/>Middle Aged<br/>Monitoring, Physiologic<br/>Mutation<br/>Myelodysplastic Syndromes--drug therapy<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Thalidomide--analogs & derivatives<br/>Tumor Suppressor Protein p53--genetics<br/>Exome Sequencing